Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 11:06 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1489–1512 of 6,754 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: CHANGE Study Clear all

Conditions: Intellectual Disability
Interventions: Physical Literacy & Food Literacy Intervention.; Behavioral
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 12 Years to 16 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Metastatic Hormone-sensitive Prostate Cancer
Interventions: JSB462, Abiraterone, Enzalutamide; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 168 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2035
U.S. locations: 21
States / cities: La Jolla, California • Santa Monica, California • Denver, Colorado + 18 more

Conditions: Acute Lymphoblastic Leukemia in Remission, Hodgkin Lymphoma in Remission, Non-Hodgkin Lymphoma in Remission, Cancer Survivorship
Interventions: Phentermine/Topiramate ER, Health Behavior and Lifestyle Counseling; Drug · Behavioral
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 12 Years to 24 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Alcohol Use, Unspecified, Relationship, Social, Depression, Anxiety
Interventions: Whole Selves; Behavioral
Lead sponsor: Boston University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 107 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Chronic Hemiparetic Stroke
Interventions: High intensity gait training in varying external environments, Treadmill walking in varying external environments; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Chicago, Illinois • Hines, Illinois

Conditions: Parkinson Disease
Interventions: 9zest app facilitated exercise; Other
Lead sponsor: 9zest. Inc.; Industry
Eligibility: 40 Years to 75 Years
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Weight Loss, Gut Microbiome, Anti-Aging
Interventions: P-IF, HH; Behavioral
Lead sponsor: Skidmore College; Other
Eligibility: 25 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Saratoga Springs, New York

Conditions: Loneliness
Interventions: Interpretation Bias Modification for Loneliness, Healthy Habits Psychoeducation and Relaxation; Behavioral
Lead sponsor: Florida State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Burnout, Professional
Interventions: hybrid asynchronous-synchronous group coaching program, treatment as usual group (TAU); Behavioral · Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 319 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 4
States / cities: Denver, Colorado • Atlanta, Georgia

Conditions: Pancreatic Ductal Adenocarcinoma (PDAC)
Interventions: Navlimetostat, mFOLFIRINOX Treatment Regimen; Drug
Lead sponsor: Daniel Nussbaum, M.D.; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2031
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Primary Immunodeficiency Diseases (PID)
Interventions: SC treatment with IGSC, 10% with rHuPH20 followed by SC/IGSC, 10% only (safety), SC treatment with IGSC, 10% with rHuPH20 followed by IV/IGSC, 10% only (safety), IV treatment with IGSC, 10%; Biological
Lead sponsor: Baxalta now part of Shire; Industry
Eligibility: 2 Years and older
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 11
States / cities: Cypress, California • Irvine, California • Los Angeles, California + 8 more

Conditions: Lung Diseases, Interstitial
Interventions: Nintedanib, Placebo; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 6 Years to 17 Years
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 9
States / cities: Los Angeles, California • Aurora, Colorado • Indianapolis, Indiana + 6 more

Conditions: Vaccine Reaction
Interventions: Not listed
Lead sponsor: physIQ, Inc.; Industry
Eligibility: Not listed
Enrollment: 130 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Irritable Bowel Syndrome, Anxiety, Quality of Life
Interventions: Yoga; Behavioral
Lead sponsor: Cooper Norcross Health; Other
Eligibility: 12 Years to 21 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Camden, New Jersey

Conditions: Alzheimer Disease
Interventions: P-tau217 Test; Other
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 55 Years to 75 Years
Enrollment: 3,400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2033
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Obesity
Interventions: Aerobic Interval Training; Other
Lead sponsor: Southern Illinois University Edwardsville; Other
Eligibility: 18 Years to 40 Years · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Edwardsville, Illinois

Conditions: Sensory Peripheral Neuropathy, Balance; Distorted, Sensation Disorders
Interventions: Walkasins; Device
Lead sponsor: RxFunction Inc.; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 5
States / cities: Baltimore, Maryland • Boston, Massachusetts • Minneapolis, Minnesota + 2 more

Conditions: Overactive Bladder
Interventions: Retrospective chart review; Other
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older · Female only
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Orange, California

Conditions: Stroke, Aphasia
Interventions: Transcranial Magnetic Stimulation; Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 80 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2020
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Marijuana Use, Pregnancy
Interventions: eSBIRT, Tailored texting; Behavioral
Lead sponsor: Wayne State University; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Colon Cancer
Interventions: Not listed
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Chronic Kidney Diseases
Interventions: High-Velocity Resistance Training, Attention; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 65 Years to 100 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Rheumatoid Arthritis, Healthy Controls
Interventions: Blood Draw, Disease Activity (DAS-28) Assessment, Skeletal Muscle Mitochondrial Respiratory Capacity, Muscle Biopsy, Body Composition, Cardiopulmonary Exercise Test (CPET), Strength Testing, Questionnaires, Skeletal Muscle Biomechanical Property Assessment; Other
Lead sponsor: Duke University; Other
Eligibility: 25 Years to 75 Years
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Depressive Disorder, Treatment-Resistant
Interventions: AVP-786 (d6-dextromethorphan hydrobromide and quinidine sulfate combination), Placebo; Drug
Lead sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 206 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 32
States / cities: Birmingham, Alabama • Bellflower, California • Costa Mesa, California + 26 more

Search by objective public record fields.

New Skills - No Scores Research Study

An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

Obesity Treatment With Phentermine-Topiramate ER in AYA Surviving Leukemia and Lymphoma

Whole Selves User Testing and Feasibility Study

Movement Amplification Gait Training to Enhance Walking Balance Post-Stroke

A Mobile Application for Telerehabilitation in Parkinson's Disease

Low Sugar Protein Pacing, Intermittent Fasting Diet in Men and Women

Computerized Intervention for Loneliness

Coaching for Advanced Practice Providers

A Study of Perioperative Navlimetostat Combined With Modified FOLFIRINOX in Patients With MTAP-Deleted Pancreatic Cancer

Tolerability and Safety of Immune Globulin Subcutaneous Solution (IGSC) and rHuPH20 in PID

A Study to Find Out How Nintedanib is Taken up in the Body and How Well it is Tolerated in Children and Adolescents With Interstitial Lung Disease (ILD)

(VIII): The Eight Study and Immunologic Response Sub-study

Standardized Yoga & Meditation Program for Stress Reduction for Adolescents With Irritable Bowel Syndrome

Epidemiology and Biomarker Study in Alzheimer's Disease

Effects of a Short-term Aerobic Interval Exercise Program on Cardiac Fat and Function in Women With Obesity: A Pilot Study

walk2Wellness: Long-term Effects of Walkasins® Wearable Sensory Prosthesis

Combined Anticholinergic Medication and Sacral Neuromodulation to Treat Refractory Overactive Bladder

TMS as a Biological Marker of Neuroplasticity

Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy

Genetic Analysis to Evaluate the Racial Difference in the Outcome of Patients With Colon Cancer

Enhancing Physical Function in Older Adults With Chronic Kidney Disease

MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics

Efficacy, Safety, and Tolerability Study of AVP-786 as an Adjunctive Therapy in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment